<DOC>
	<DOCNO>NCT00960076</DOCNO>
	<brief_summary>The purpose study compare reduction A1C subject take Saxagliptin Metformin XR vs. uptitrated Metformin XR .</brief_summary>
	<brief_title>An 18 Week Efficacy Safety Study Saxagliptin Metformin XR Combination Subjects With Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Saxagliptin</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>Type 2 diabetic take metformin IR XR great equal 850mg less equal 1500mg least 8 week prior screen A1c : 7.511 % ( screen ) BMI le equal 45 kg/m2 Significant cardiovascular history Active liver disease , renal impairment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>78 Years</maximum_age>
	<verification_date>August 2011</verification_date>
	<keyword>T2DM</keyword>
	<keyword>Metformin</keyword>
	<keyword>A1c</keyword>
</DOC>